Vivienne blinked, taken aback. "Really?"
Recovering quickly, she put on a mask of modest brilliance. "It was just an idea I threw out there. I didn't expect you to be so impressed by it."
Julian looked up at her, unspoken admiration shining in his eyes. "Cellular repair is the holy grail of gene therapy. This approach heavily utilizes homologous recombination and the CRISPR gene-editing system. Compared to traditional methods, it bypasses the risks of random insertion mutations. And using a homologous control group is the fastest way to verify the results. It's a stroke of genius that you thought of this."
Vivienne didn't understand a single syllable of the scientific jargon, but the praise went straight to her head. "It wasn't that difficult, really."
"So, what are the final conclusions?" Julian asked.
"Conclusions?" Vivienne echoed blankly. "Weren't they included in the file?"
"No. The proposal only contains the raw data."
Panic seized her chest. She had no idea what the conclusions were—she had stolen the entire concept from Willow. Desperate to cover her tracks, she lied through her teeth. "Oh, right, I remember now. We haven't finalized the conclusions because the sample size isn't large enough to be statistically significant yet. I'll be overseeing the next phase of testing soon."
Julian nodded, satisfied with her excuse. "It's a phenomenal concept. I want to roll this out as an internal initiative across the company. How would you feel about taking the lead as the project director?"
Normally, Vivienne would kill for that kind of spotlight, but this time, it terrified her. She quickly waved off the offer. "It was just a fleeting moment of inspiration. If we want to implement it company-wide, it's going to take months of rigorous validation. Plus, my hands are completely tied with the Merit Biotech deal right now. I just don't have the bandwidth."


VERIFYCAPTCHA_LABEL
Comments
The readers' comments on the novel: Three Years Forgotten, Why Go Crazy When I Say Goodbye?